In spite of advances in Immunohematology and infectious marker testing in recent years, the rates of alloimmunization and infectious marker positivity remains high among multiply transfused patients like thalassemics. Provision of safe and adequate blood supply to these patients is a key to improving their quality-of-life and longevity.
A survey of the occurrence of lympho-agglutinins was carried out on seeds of 150 species of wild and cultivated plants. Potent agglutinins were detected in 17 extracts by employing lymphocytes of man, guinea pig, goat and sheep in the bioassay. Except for one species each of Mimosoideae, Euphorbiaceae and Clusiaceae, all the agglutinins were found in fabaceous seeds. Two of the agglutinins, namely, Parkia biglandulosa and Erythrina arborescens, were found to be monospecific for guinea pig and human lymphocytes, respectively, while the others agglutinated lymphocytes of 2-4 different species. The agglutination inhibition tests revealed the predominance of galactose (or its derivatives) binding lectins over those specific for glucose-mannose series.
Lympho-agglutinins have been detected and characterized in 31 plant species. Out of these, 14 agglutinated
only the neuraminidase-treated cells. The lectin-rich genera included Crotalaria and Erythrina (Fabaceae),
Amaranthus (Amaranthaceae), Artocarpus (Moraceae) and Clerodendron (Verbenaceae). The new lectins varied in
their potency and biological action spectra. The 3 Artocarpus species were found to be exceptionally potent and
specific for melibiose, an α-D-galactoside. Among the most effective sugar inhibitors for other lectins were Nacetyl-
galactosamine, lactose, galactose and asialofetuin/fetuin
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.